The Protein Sequencing Companytm, announces participation in an upcoming DNAnexus webinar focused on the role of proteomics in multi-omics research. This discussion will explore how ...

Evinova, a global clinical trial technology company with proven published outcomes for sponsors, sites and patients, announced today an agreement with Quantum Leap Healthcare Collaborativetm (QLHC) to ...

Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Company ™, today announced that ...

Quantum-Si's next-gen protein sequencing tech and growth partnerships show promise, but high costs, financial risks, and ...

Quantum-Si aims to revolutionize protein sequencing amidst technological hurdles, uncertain advancements, and market ...

After an injury, your sacroiliac (SI) joint needs time to heal. So you’ll need to take a break from some of your usual activities, especially those that may have caused the problem, like running ...

Highlights,Sanctuary Advisors LLC and other financial entities have expanded their stakes in Quantum-Si.,Quantum-Si’s trading range reflects substantial movement over the past year.,The company is ...

Stock analysts at HC Wainwright issued their FY2029 EPS estimates for shares of Quantum-Si in a note issued to investors on Tuesday, March 4th. HC Wainwright analyst S. Ramakanth expects that the ...

Alliance Global Partners lowered the firm’s price target on Quantum-Si (QSI) to $3.65 from $3.75 and keeps a Buy rating on the shares following the Q4 report. The company targets significant ...

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is ...

Quantum-Si incorporated (NASDAQ ... 2024 was an important year in the commercialization of our next-generation protein sequencing technology, the Platinum instrument. The year began with our ...